Ban Doctorates 'By the Pound'

Alongside triviality, unoriginality and, nowadays, dishonesty, one attribute for which journal editors are particularly vigilant in papers is obesity. Some research reports are, of course, necessarily bulky documents. This is especially true in fields such as high energy physics, where a collaboration of several dozen physicists and machine staff may be necessary to describe the design, outcome and analysis of experiments that take many months. At the other end of the scale, few if any worthwh

Written byBernard Dixon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Alongside triviality, unoriginality and, nowadays, dishonesty, one attribute for which journal editors are particularly vigilant in papers is obesity. Some research reports are, of course, necessarily bulky documents. This is especially true in fields such as high energy physics, where a collaboration of several dozen physicists and machine staff may be necessary to describe the design, outcome and analysis of experiments that take many months. At the other end of the scale, few if any worthwhile contributions to the literature today can be as effectively succinct as the Nature letter in which Francis Crick and Jim Watson first revealed to the world their discovery of the DNA double helix and its biological implications.

Yet unduly detailed or prolix accounts of work that is otherwise acceptable and publishable continue to arrive through editorial letterboxes, provoking both editors and referees to demand appropriate surgery. Neither they nor readers and purchasers want gratuitous ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies